{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:17:02Z","timestamp":1791605822722,"version":"4.3.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cgfr.co.uk","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.cytogfr.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T19:28:24Z","timestamp":1376681304000},"page":"539-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice"],"prefix":"10.1016","volume":"24","author":[{"given":"Mario","family":"Rotondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Coperchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Chiovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2013.08.001_bib0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI114265","article-title":"Neutrophil-activating peptide-1\/interleukin 8 a novel cytokine that activates neutrophils","volume":"84","author":"Baggiolini","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0010","doi-asserted-by":"crossref","first-page":"95S","DOI":"10.1378\/chest.105.3_Supplement.95S","article-title":"Interleukin-8 and related chemotactic cytokines. The Giles Filley Lecture","volume":"105","author":"Baggiolini","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0167-5699(00)01672-8","article-title":"Chemokines in inflammation and immunity","volume":"21","author":"Baggiolini","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1189\/jlb.0208125","article-title":"The functional significance behind expressing two IL-8 receptor types on PMN","volume":"86","author":"Stillie","year":"2009","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0025","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.4049\/jimmunol.171.12.6714","article-title":"IL-8-mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor","volume":"171","author":"Schraufstatter","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-5793(92)80909-Z","article-title":"Interleukin-8: a chemotactic and inflammatory cytokine","volume":"307","author":"Baggiolini","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0035","first-page":"60","article-title":"IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor MCAF mRNA expression in a human astrocytoma cell line","volume":"74","author":"Kasahara","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0040","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/IAI.65.8.3218-3224.1997","article-title":"Mechanisms involved in helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line MKN45","volume":"65","author":"Aihara","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0045","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.4049\/jimmunol.159.11.5550","article-title":"Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells","volume":"159","author":"Hobbie","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0050","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/S0021-9258(19)74429-9","article-title":"Regulation of interleukin 8 gene expression by oxidant stress","volume":"268","author":"DeForge","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0055","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1074\/jbc.272.24.15366","article-title":"Stimulation of interleukin-8 production by okadaic acid and vanadate in a human promyelocyte cell line an HL-60 subline. Possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-kappaB activation","volume":"272","author":"Sonoda","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0060","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1840701","article-title":"Structure and functional expression of a human interleukin-8 receptor","volume":"253","author":"Holmes","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0065","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1126\/science.1891716","article-title":"Cloning of a complimentary DNA encoding a functional human interleukin-8 receptor","volume":"253","author":"Murphy","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0070","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0075","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1073\/pnas.90.8.3574","article-title":"Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg","volume":"90","author":"Clark-Lewis","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2003.10.006","article-title":"CXC chemokines in angiogenesis of cancer","volume":"14","author":"Strieter","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","article-title":"CXC chemokines the regulatory link between inflammation and angiogenesis","volume":"25","author":"Romagnani","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0090","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.99-0963com","article-title":"Differential expression and responsiveness of chemokines receptors CXCR1-3 by human microvascular endothelial cells and umbilical vein endothelial cells","volume":"14","author":"Salcedo","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10456-005-5208-4","article-title":"Autocrine role of interleukin-8 in induction of endothelial cell proliferation survival migration and MMP-2 production and angiogenesis","volume":"8","author":"Li","year":"2005","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1309\/VPL5-R3JR-7F1D-6V03","article-title":"Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma","volume":"125","author":"Varney","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0105","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.bjc.6605055","article-title":"CXCR1 and CXCR2 enhances human melanoma tumourigenesis growth and invasion","volume":"100","author":"Singh","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1158\/0008-5472.CAN-08-3378","article-title":"Host CXCR2-dependent regulation of melanoma growth angiogenesis and experimental lung metastasis","volume":"69","author":"Singh","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0115","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","article-title":"The CXC chemokine receptor 2, CXCR2 is the putative receptor for ELR+CXC chemokine-induced angiogenic activity","volume":"165","author":"Addison","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/er.2006-0044","article-title":"Role of chemokines in endocrine autoimmune diseases","volume":"28","author":"Rotondi","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0125","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ijc.24383","article-title":"CXC-chemokine\/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer","volume":"125","author":"Matsuo","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jc.2012-2555","article-title":"Interferon-g and tumor necrosis factor-a sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumorrelated inflammation?","volume":"98","author":"Rotondi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0135","first-page":"328","article-title":"Thyroid follicular cells produce interleukin-8","volume":"75","author":"Weetman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/thy.2009.0242","article-title":"Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin","volume":"1","author":"Yamazaki","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0145","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1210\/jc.2011-2514","article-title":"Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production","volume":"97","author":"Gillespie","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0150","first-page":"435","article-title":"Serum cytokines in thyrotoxicosis","volume":"84","author":"Siddiqi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0155","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12020-009-9240-9","article-title":"Association studies of interleukin-8 gene in Graves\u2019 disease and Graves\u2019 ophthalmopathy","volume":"3","author":"Gu","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/thy.2000.10.445","article-title":"Serum interleukin-8 levels in thyroid diseases","volume":"10","author":"Krassas","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0165","doi-asserted-by":"crossref","DOI":"10.1089\/jir.2012.0080","article-title":"Type I and type II interferons inhibit both basal and tumor necrosis factor-\u03b1-induced CXCL8 secretion in primary cultures of human thyrocytes","author":"Rotondi","year":"2013","journal-title":"J Interf Cytok Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0170","doi-asserted-by":"crossref","first-page":"270149","DOI":"10.4061\/2011\/270149","article-title":"Clinical utility of serum interleukin-8 and interferon-alpha in thyroid diseases","volume":"2011","author":"Kobawala","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","article-title":"Expression of IP-10\/CXCL10 and MIG\/CXCL9 in the thyroid and increased levels of IP-10\/CXCL10 in the serum of patients with recent-onset Graves\u2019 disease","volume":"161","author":"Romagnani","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0180","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.4049\/jimmunol.168.5.2470","article-title":"A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transform nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis","volume":"168","author":"Wang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/jir.2005.25.547","article-title":"Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects","volume":"25","author":"Antonelli","year":"2005","journal-title":"J Interf Cytok Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0190","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/eje.1.02137","article-title":"Increased serum CXCL10 in Graves\u2019 disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se but is specifically sustained by the autoimmune inflammatory process","volume":"5","author":"Antonelli","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0195","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.2174\/138161211798157559","article-title":"The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-\u03b3 inducible chemokines and their receptor","volume":"17","author":"Rotondi","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0200","first-page":"741","article-title":"Serum levels of cytokines in children and adolescents with Graves\u2019 disease and non-toxic nodular goiter","volume":"6","author":"Bossowski","year":"2001","journal-title":"J Pediatr Endocrinol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1570453","article-title":"T3 regulates the production of IL-6 and IL-8 in human bone marrow stromal and osteoblast-like cells","volume":"157","author":"Siddiqi","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/cyto.1999.0557","article-title":"Corticosteroids and interferons inhibit cytokine-induced production of IL-8 by human endothelial cells","volume":"12","author":"Nyhl\u00e9n","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0215","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1073\/pnas.89.19.9049","article-title":"Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon cytokine network\/tumor necrosis factor\/nuclear run-on assay\/neutrophil chemotaxis\/inflammation","volume":"89","author":"Oliveira","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0220","first-page":"177","article-title":"Interferon-gamma inhibits interleukin-8 production by human polymorphonuclear leucocytes","volume":"78","author":"Cassatella","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0225","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4049\/jimmunol.177.2.822","article-title":"Mechanism of IFN-\u03b2-mediated inhibition of IL-8 gene expression in astroglioma cells","volume":"177","author":"Nozell","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0230","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2567.2001.01189.x","article-title":"The 3\u2032-untranslated region of human interleukin-8 mRNA suppresses IL-8 gene expression","volume":"102","author":"Yu","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0235","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1744-313X.2005.00536.x","article-title":"Lack of association between pro-inflammatory cytokine, IL-6, IL-8 and TNF-alpha gene polymorphisms and Graves\u2019 disease","volume":"32","author":"Chen","year":"2005","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00832002","article-title":"Chemokines in rheumatoid arthritis","volume":"20","author":"Szekanecz","year":"1998","journal-title":"Springer Semin Immun"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0245","first-page":"632","article-title":"Cytokine IL-6 and chemokine IL-8 gene polymorphisms among rheumatoid arthritis patients in Taiwan","volume":"26","author":"Lo","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0250","article-title":"Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of HCV and thyroiditis","author":"Blackard","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0255","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.1002631","article-title":"IFN-\u03b1 mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms","volume":"186","author":"Akeno","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0260","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2008.08.001","article-title":"HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity","volume":"31","author":"Akeno","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0265","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2741\/1579","article-title":"The role of interleukin-8 in cancer cells and microenvironment interaction","volume":"10","author":"Yuan","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0270","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/ijc.22930","article-title":"Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells","volume":"121","author":"Yao","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0275","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-07-1162","article-title":"Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer","volume":"67","author":"Araki","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0280","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/sj.onc.1210536","article-title":"HIF-1 and NF-\u03baB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells","volume":"26","author":"Maxwell","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0285","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-03-0760","article-title":"The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8","volume":"10","author":"DeLarco","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0290","first-page":"2786","article-title":"Nuclear factor-\u03baB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8","volume":"9","author":"Karashima","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0295","first-page":"3167","article-title":"Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-\u03baB","volume":"9","author":"Mian","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0300","first-page":"2104","article-title":"Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer","volume":"6","author":"Inoue","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0002-9440(10)64164-8","article-title":"Fully humanized neutralizing antibodies to interleukin-8 ABX-IL8 inhibit angiogenesis tumor growth and metastasis of human melanoma","volume":"161","author":"Huang","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0310","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1074\/jbc.275.10.6868","article-title":"Chemokine receptors CXCR-1\/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells","volume":"275","author":"Venkatakrishnan","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0315","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.4049\/jimmunol.171.12.6714","article-title":"IL-8 mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor","volume":"171","author":"Schraufstatter","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0320","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1074\/jbc.273.17.10690","article-title":"Multiple signaling pathways of human interleukin-8 receptor A. Independent regulation by phosphorylation","volume":"273","author":"Richardson","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0325","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","article-title":"The role of Interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis","volume":"7","author":"Brat","year":"2005","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0330","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival proliferation and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0335","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1128\/MCB.16.8.4231","article-title":"Involvement of the transcription factor NF-\u03baB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress","volume":"16","author":"Shono","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0340","first-page":"1105","article-title":"Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis","volume":"151","author":"Luca","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0345","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/cvr\/cvm102","article-title":"Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead","volume":"78","author":"Van Hinsbergh","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0350","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1074\/jbc.C800207200","article-title":"CXCL8\/IL8 stimulates vascular endothelial growth factor VEGF expression and the autocrine activation of VEGFR2 in endothelial cells by activating NF-\u03baB through the CBM Carma3\/Bcl10\/Malt1 complex","volume":"284","author":"Martin","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0355","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1359-6101(01)00016-8","article-title":"Interleukin-8 and human cancer biology","volume":"12","author":"Xie","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0065-230X(10)06003-3","article-title":"CXC chemokines in cancer angiogenesis and metastases","volume":"106","author":"Keeley","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0365","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5301\/JBM.2012.9261","article-title":"Interleukin-8 CXCL8 in tumor associated non-vascular extracellular fluids: its diagnostic and prognostic values. A review","volume":"27","author":"Kotyza","year":"2012","journal-title":"Int J Biol Marker"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0370","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-12-12","article-title":"IL-8 as a urinary biomarker for the detection of bladder cancer","volume":"12","author":"Urquidi","year":"2012","journal-title":"BMC Urol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0375","first-page":"177","article-title":"Prognostic and predictive potentialmolecular biomarkers in colon cancer","volume":"106","author":"Nastase","year":"2011","journal-title":"Chirurgia (Bucur)"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0380","first-page":"464","article-title":"Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma","volume":"52","author":"Yoshida","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0385","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.10116","article-title":"Establishment of a non-tumorigenic papillary thyroid cell line FB-2 carrying the RET\/PTC1 rearrangement","volume":"97","author":"Basolo","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0390","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Borrello","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0395","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI200522758","article-title":"The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells","volume":"115","author":"Melillo","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0400","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"54","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0405","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer autoimmunity and inflammation: clinical and molecular studies","volume":"72","author":"Muzza","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0410","first-page":"5996","article-title":"Interleukin- 8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis","volume":"9","author":"Ren","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0415","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1023\/A:1012527006566","article-title":"Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance","volume":"12","author":"Ruka","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0420","first-page":"208","article-title":"Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukaemia","volume":"84","author":"Molica","year":"1999","journal-title":"Haematology"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0425","first-page":"525","article-title":"Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma","volume":"9","author":"Retzlaff","year":"2002","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0430","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2001.19.2.577","article-title":"Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival","volume":"19","author":"Ugurel","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0435","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5858\/2000-124-0520-EOTCRC","article-title":"Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells","volume":"4","author":"Tecimer","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0440","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/joe.0.1700513","article-title":"GRO-alpha in normal and pathological thyroid tissues and its regulation in thyroid-derived cells","volume":"3","author":"Aust","year":"2001","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0445","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-10-2041","article-title":"Identification of soluble candidate biomarkers of therapeutic response to sunitinib in medullary thyroid carcinoma in preclinical models","volume":"17","author":"Broutin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0450","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1535-7163.MCT-07-0307","article-title":"A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts revealing IL-8 as a potential pharmacodynamic biomarker","volume":"7","author":"Crawford","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0455","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-09-3965","article-title":"Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma","volume":"70","author":"Huang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2013.08.001_bib0460","first-page":"3445","article-title":"Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype","volume":"5","author":"Duan","year":"1999","journal-title":"Clin Cancer Res"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T22:46:33Z","timestamp":1688424393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610113000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1359610113000762"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.08.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}